Understanding Ovarian Cancer and Its Risks

Overview of Ovarian Cancer

Ovarian cancer ranks as one of the top causes of cancer-related fatalities among women. In the United States, it is the fifth most common cause of cancer deaths among females, with over 85% of cases diagnosed at advanced stages when the cancer has already spread beyond the ovaries. Identifying specific risk factors associated with ovarian cancer can facilitate early screening for women at greater risk.

The Role of Menstrual Pain

Menstrual pain, clinically known as dysmenorrhea, is linked to increased inflammation and has been evaluated concerning the risk of ovarian cancer. Similar to other inflammatory conditions such as endometriosis and pelvic inflammatory disease, menstrual pain may play a role in the development of ovarian cancer.

Research Study on Menstrual Pain and Ovarian Cancer Risk

Study Background

A recent study published in the International Journal of Cancer aimed to determine the relationship between severe menstrual pain and the risk of ovarian cancer. Researchers from the Ovarian Cancer Association Consortium (OCAC), an international collaboration dedicated to understanding ovarian cancer risk factors, conducted this study. It involved data from 10,592 women diagnosed with ovarian cancer and 13,320 women without the disease.

Methodology

Participants completed a questionnaire that included both direct and indirect inquiries about their experiences with menstrual pain. Direct questions asked respondents if they had experienced severe menstrual pain, while indirect questions addressed the use of over-the-counter medications, such as oral contraceptives, hormones, NSAIDs, or intrauterine devices, to manage menstrual pain. Any menstrual pain that necessitated these interventions was classified as severe.

Findings on Severe Period Pain

Increased Risk of Ovarian Cancer

The study found that women diagnosed with ovarian cancer were more likely to report severe menstrual pain compared to those without the disease. Women with ovarian cancer were also more likely to be childless, have used oral contraceptives for shorter durations, and have a family history of breast or ovarian cancer. Notably, sites that posed indirect questions reported only 5.3% instances of severe menstrual pain, while those that used direct questioning reported 30.3%.

Women who reported experiencing severe menstrual pain had a 17% heightened risk of developing ovarian cancer compared to those without severe pain. Furthermore, women who endured severe pain for more than 12 years faced an 18% increased risk. The association between severe menstrual pain and ovarian cancer risk was particularly strong for the clear cell and borderline serous subtypes of ovarian carcinoma.

Study Limitations

While the findings suggest a small increase in risk for women with severe menstrual pain, limitations exist. Participants may have difficulty recalling their symptoms accurately, and some may have had undiagnosed endometriosis, both of which could influence the study’s outcomes. Additionally, the variability in questions regarding menstrual pain across study sites may have affected the results. Most participants were white women (87%), raising concerns about the applicability of the findings to other ethnic groups.

Conclusion

This research highlights a potential link between severe menstrual pain and an increased risk of ovarian cancer, emphasizing the importance of further investigation into this association. Early recognition of risk factors could lead to improved screening and better outcomes for women at risk.

Reference

Babic, A., Harris, H., Vitonis, A., Titus, L., Jordan, S., & Webb, P. et al. (2017). Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association Consortium. International Journal Of Cancer, 142(3), 460-469. http://dx.doi.org/10.1002/ijc.31010